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Elucidating the precise mechanism(s) by which cytolytic T 
lymphocytes (CTLs) destroy target cells is important since 
CD4 + and CD8 + CTLs are involved in AIDS, autoimmunity, 
and immune responses against viruses, tumors, and 
transplants. Recent advances in deciphering the mecha- 
nisms of CTL-induced lysis on a molecular level clarify the 
existence and utilization of two separate pathways: the 
formation of pores in target cell membranes by secreted 
perforin followed by target cell penetration by granzymes 
cosecreted with perforin, and ligand-mediated triggering 
of target cell surface receptors that induce apoptosis (see 
Figure 1; reviewed by Henkart, 1994; Berke, 1994). At 
present, it appears that all acute cytotoxicity by CTLs can 
be accounted for by these two mechanisms. However, 
tumor necrosis factor ~ (TNF~) is expressed on the surface 
of most CTLs, and although it mediates only a relatively 
slow lytic process in vitro, it may also contribute to cytotox- 
icity in vivo. 
CTL-Mediated Lysis Is an Apoptotic Process 
The delivery of the "lethal hit" by a CTL induces target 
cell apoptosis, a form of programmed cell death. During 
apoptosis, the cell's chromatin condenses, its membrane 
blebs, and its DNA fragments into oligonucleosome-length 
DNA fragments. These events are followed by cell shrink- 
age, dilation of endoplasmic reticulum, and, finally, cell 
fragmentation, resulting in the formation of sealed mem- 
brane fragments (apoptotic bodies). The stage of the mi- 
totic cycle to which the target cell is committed influences 
the fate of the target; quiescent (GO) cells are refractory 
to CTL-induced DNA fragmentation, whereas G1 stage 
targets are susceptible (Nishioka and Welsh, 1994). 
The Secretory Perforin-Granzyme Pathway 
of CTL.Mediated Lysis 
A cytocidal mechanism involving the secretion of the lyric 
protein perforin (cytolysin) and a series of natural serine 
proteases (granzymes), both of which are stored in unique 
secretory CTL granules, was proposed by Henkart and 
others (Henkart, 1994; Podack et al., 1991) (Figure 1, 
right). According to this mechanism, T cell receptor-medi- 
ated binding of an appropriate target by a CTL stimulates a 
Ca÷-dependent degranulation process in the effector cell. 
Perforin and granzymes, thus released into the localized 
environment between the effector and target, would then 
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Figure 1. Schematic Diagram of the Mechanisms for CTL-Mediated Target Cell Lysis 
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cause target cell lysis, but spare the effector cell; target 
cell penetration of the secreted granzymes through poly- 
perforin pores produced in the target cell plasma mem- 
brane has been postulated to account for DNA fragmen- 
tation. 
Ca÷-dependent granule exocytosis has been demon- 
strated in some types of CTL-mediated target cell lysis. 
In addition, a secretory role for CTL granules is supported 
by their kinesin-dependent motility on microtubules in vitro 
(Burkhardt et al., 1993). The rearrangement in CTLs of 
cytoplasmic granules, the microtubule-organizing center, 
and the Golgi apparatus proximal to the contact zone with 
bound target cells is also consistent with involvement of 
granule exocytosis, as is the temporary inactivation of NK 
cells and some CTLs upon lysing target cells. 
Initially, perforin was viewed as the exclusive mediator 
of CTL- and NK-induced lysis. However, secreted perforin 
alone induces lysis without fragmentation of target cell 
DNA, a hallmark of CTL-mediated target cell lysis. Re- 
cently, cooperation between secreted granzyme(s) and 
perforin has been shown to cause typical CTL-induced 
lysis, including DNA fragmentation (reviewed by Henkart, 
1994). For instance, transfection of CTLs with a granzyme 
A antisense expression vector partially reduces their lytic 
activity, and CTLs from granzyme B knockout mice show 
slower DNA fragmentation as well as reduced lysis of tar- 
get cells (Heusel et al., 1994). Also, nonlytic rat basophilic 
leukemia cells simultaneously transfected with perforin 
and granzyme A can mediate both antibody-redirected cy- 
totoxicity and target cell DNA breakdown, whereas rat ba- 
sophilic leukemia cells transfected with granzyme A alone 
do not. Furthermore, rat basophilic leukemia cells trans- 
fected with perforin alone can lyse, albeit with a low effi- 
ciency, both nucleated and red blood cells, but without 
causing DNA fragmentation in the nucleated cells (Shiver 
et al., 1992). 
Entrance of granzymes secreted by CTLs into target 
cells is postulated to occur through pores produced in the 
target cell's membrane by perforin secreted in parallel 
(Henkart, 1994) (Figure 1, right). Although the precise 
mode and site of granzyme-perforin collaboration are not 
well understood, the collaboration is consistent with expo- 
sure to granzyme A alone inducing DNA fragmentation in 
permeabilized cells and target cells loaded with aprotinin, 
a protease inhibitor, being refractory to both CTL-medi- 
ated lysis and DNA fragmentation (reviewed by Henkart, 
1994). While nuclear disintegration is obviously sufficient 
to cause target cell death, it is not an obligatory function 
of the CTL lytic machinery, which can effectively lyse 
some, but not all, enucleated target cells (cytoplasts) (Sili- 
ciano and Henney, 1978). 
To date, all evidence for functional target cell-induced 
release of perforin during specific CTL-mediated lysis is 
still indirect. Moreover, unequivocable molecular evidence 
for the directional transfer of perforin, granzymes, or both 
from effector CTLs to the specific target cells with which 
they physically interact is still lacking. Also, the failure of 
perforin antibodies to block CTL-meditated lysis is enig- 
matic, although the intercellular space between a CTL and 
its target may be inaccessible to an antibody. 
Evidence for a Lyric Pathway Not Involving Perforin 
and Granzyme Secretion: Lysis under Ca +.Free 
Conditions and by Perforin. and 
Granzyme.Devoid CTLs 
The model of perforin- and granzyme-mediated lymphocy- 
totoxicity involves extracellular Ca + at three distinct steps: 
regulation of secretion of the lytic granule constituents 
perforin and granzymes, binding of secreted perforin to 
the membranes of target cells, and polymerization of per- 
forin to polyperforin, the latter of which is believed to be 
involved in lytic pore formation. However, with certain tar- 
get cells, such as the murine leukemia EL4, efficient CTL- 
mediated lysis can occur in the absence of extracellular 
Ca + (<10 -8 M) or detectable granzyme secretion or forma- 
tion of polyperforin pores. Thus, a universal scheme of 
lymphocytotoxicity hat involves Ca+-dependent granule 
exocytosis, perforin polymerization, and the lytic activity 
of perforin cannot account for all instances of lymphocyto- 
toxicity (reviewed by Berke, 1991). 
Furthermore, in vivo primed class I major histocompati- 
bility complex-restricted CTLs (alloreactive peritoneal ex- 
udate cytolytic lymphocytes [PELs]) and their cytocidal 
hybridomas, which are essentially devoid of perforin and 
granzymes, display potent and specific cytolytic activity 
(Berke and Rosen, 1988; Berke et al., 1993; Helgason et 
al., 1992). Perforin-negative class II major histocompati- 
bility complex-restricted CD4 + CTLs have also been re- 
ported (see Henkart, 1994). 
Insights into the role of perforin in CTL production and 
cytolytic function(s) were provided by studies conducted 
in parallel by four different groups utilizing mice in which 
the perforin gene had been destroyed by homologous re- 
combination (Kagi et al., 1994a, 1994b; Kojima et al., 1994; 
Lowin et al., 1994; Walsh et al., 1994a). Although an oblig- 
atory role of perforin in lymphocytotoxicity was favored 
in the first report (Kagi et al., 1994a), subsequent work 
reported by all four groups demonstrated considerable cy- 
tocJdal activity of perforin-devoid CTLs against certain 
(Fas-expressing; see below) target cells, cytocidal activity 
that was often indistinguishable from that of perforin- 
containing CTLs. Furthermore, the perforin knockout mice 
can reject intraperitoneally administered tumor allografts 
and produce a powerful PEL-CTL in response to these 
allografts, and their lymphocytes can generate alloreac- 
tive CTLs in mixed lymphocyte cultures. These findings 
strongly support a perforin-independent cytocidal mecha- 
nism for CTLs. 
In the perforin knockout mice, a virus-specific CTL re- 
sponse against a lymphocytic choriomeningitis virus 
(LCMV)-infected fibroblast subline (MC57) was not ob- 
served (Kagi et al., 1994a; Walsh et al., 1994a). However, 
normal CTL production and activity against LCMV peptide- 
presenting EL4 target cells, which express the Fas anti- 
gen, occur (Clark et al., 1995). Thus, failure of CTLs from 
perforin knockout mice to lyse virus-infected MC57 fibro- 
blasts in vivo (Kagi et al., 1994a) is probably due to lack 
of Fas expression by the MC57 fibroblasts, rather than 
failure of the mice to produce LCMV-specific CTLs. Im- 
portantly, despite producing LCMV-specific CTLs, perforin 
knockout mice are unable to control LCMV infection, do 
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not elicit CD4 ÷ T cell-mediated elayed-type hypersensi- 
tivity responses when exposed to the virus through their 
footpads, and eventually succumb to the virus by an un- 
known mechanism (Walsh et al., 1994a). 
CTL Triggering of Internal Target Disintegration: 
A Cytolytic Pathway That Does Not Require 
Secretion of Perforin or Granzymes 
Evidence that CTLs invoke rapid degradation of the target 
cell's nucleus and its content (a hallmark of CTL-induced 
apoptosis) were provided by Russell (1983). Although tar- 
get cell binding and the delivery of the lethal hit were dem- 
onstrated to be distinct events in the lytic process (re- 
viewed by Martz, 1993), they do not necessarily involve 
distinct molecular entities of the CTL. This first led to the 
hypothesis that target cell destruction occurs as a direct 
consequence of its binding to the CTL and later to the 
proposal that upon CTL-target conjugation, a CTL mem- 
brane ligand(s) triggers the target's demise by cross- 
linking indigenous apoptosis-inducing target cell surface 
molecules, such as APO-1/Fas (Berke, 1991) (Figure 1, 
left). 
Cell death resulting from interactions with multivalent 
ligands of apoptosis-inducing cell surface receptors has 
been demonstrated in a variety of systems (reviewed by 
Krammer et al., 1994). Apoptosis of leukemic cells can 
be induced by high affinity antibodies, but not by their 
corresponding F(ab)2 fragments, against he surface mem- 
brane receptor APO-1/Fas. Likewise, TNF cytotoxicity can 
be induced by antibodies against membrane-bound TNF(z 
receptors in the absence of complement (Engelmann et 
al., 1990). These two examples indicate that cross-linking 
of an appropriate target cell surface receptor may be re- 
quired and can be sufficient o induce cell death, although 
by an apparently distinct mechanism (Schulze-Osthoff et 
al., 1994). Fas is a transmembrane 48 kDa glycoprotein 
that is structurally homologous to the TNFe and nerve 
growth factor receptors and is widely expressed on both 
lymphoid and nonlymphoid tissues. An intracellular do- 
main of APO-1/Fas is homologous to the death domain 
of the p55 TNF receptor and, hence, might be essential 
for transmitting the apoptotic signal (Tartaglia et al., 1993). 
How cross-lin king of Fas by Fas antibody or by a Fas ligand 
(FasL) expressed on the surface of CTLs kills cells is still 
not clear. Interestingly, some Fas signaling may actually 
activate cells rather than induce their destruction. This is 
not surprising since the external signals that can produce 
apoptosis are as varied as those that induce differentiation 
and proliferation. 
Fas involvement in Ca÷-independent, CTL-mediated ly- 
sis was decisively demonstrated by Rouvier et al. (1993) 
and confirmed by Walsh et al. (1994b). However, it ap- 
pears that Fas involvement is not limited to the Ca +- 
independent lymphocytotoxicity. The cytolytic activity of 
in vitro stimulated alloreactive CD8 ÷ CTLs derived from 
perforin knockout mice is strictly Ca ÷ dependent and Fas 
mediated (Kojima et al., 1994). Involvement of Fas in li- 
gand-induced cell death is supported by studies with Ipr 
(lymphoproliferation) mice, whose Fas expression is de- 
fective. Two spontaneous mutations, Ipr and Ipr~, in the 
Fas gene of these mice have been identified. Activated 
lymphocytes and thymocytes from Ipr mice are refractory 
to the apoptotic signals delivered by either Fas antibodies 
or perforin-free CTLs. Identification and characterization 
of the FasL expressed on CTL membranes has facilitated 
elucidation of the role of Fas in CTL-mediated lysis (Suda 
et al., 1993). Activated T cells from homozygous gld mice, 
which have a point mutation in the carboxy-terminal extra- 
cellular domain of the FasL, do not lyse Fas ÷ target cells 
(Ramsdell et al., 1994). Furthermore, a Fas-Fc fusion pro- 
tein is an effective inhibitor of CTL-mediated lysis. 
The FasL is a 40 kDa type II transmembrane protein of 
the TNF family that is expressed on activated T cells and 
is related to the emerging family of cell surface cytokines. 
Purified FasL can lyse Fas-expressing cells, and non- 
lymphoid COS cells expressing FasL exhibit cytocidal ac- 
tivity against Fas-expressing target cells (Suda et al., 
1993). Thus, the target cell specificity for lysis induced 
by FasL-expressing CTLs and the sparing of bystanders 
during CTL-mediated lysis are puzzling unless the FasL 
is up-regulated only during specific CTL-target cell bind- 
ing. A related issue is whether Fas-based CTL-induced 
killing must involve the CTL's FasL or can be affected by 
CTL triggering of indigenous FasL-Fas interactions on 
the target cell. Such an induced suicidal mechanism has 
recently been demonstrated at the single cell level in 
apoptosis of T cell receptor-activated T cell hybridomas 
(reviewed by Strasser, 1995) and may be important in neg- 
ative selection as well as in termination of immune re- 
sponse to antigen. 
The FasL-Fas-based CTL lytic mechanism probably ac- 
counts for the significant lymphocytotoxicity detected in 
perforin knockout mice (Kagi et al., 1994b; Lowin et al., 
1994; Kojima et al., 1994; Walsh et al., 1994a), for lysis 
by CD4 ÷ CTLs (Ju et al., 1994), and for lysis by perforin- 
deficient in vivo primed PEL-CTLs and their cytocidal hy- 
bridomas (Berke et al., 1993; Helgason et al., 1992; Walsh 
et al., 1994b). The FasL-Fas pathway of CTL-mediated 
lysis is compatible with some target cells, such as EL4 
leukemia, being lysed by CTLs under Ca÷-free conditions 
(in which CTL granule exocytosis is not detected and per- 
forin is not lytic). 
Summary 
The potent and specific lytic activity of CTLs can occur 
by at least two distinct pathways. In the secretion and 
perforin-mediated pathway, the direct effect(s) on the tar- 
get cell membrane of the pore-forming agent perforin, 
probably in conjunction with granzymes, also secreted 
from the CTLs, causes the target's demise. Intercyto- 
plasmic transfer of granzymes is believed to be involved 
in inducing target apoptosis. In the Fas-mediated pathway, 
engagement of a CTL membrane ligand with an apoptosis- 
inducing target cell surface receptor, such as the FasL with 
Fas, triggers programmed isintegration of the CTL-bou nd 
target; secretion of granzymes and pore formation by per- 
forin are not involved in this receptor-mediated mecha- 
nism. Despite the fundamental differences in their onset 
for both pathways, the downstream sequence of events 
that culminate in target cell apoptosis appears to be simi- 
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